Susceptibility of clinical isolates of Pseudomonas aeruginosa to antimicrobial agents
- 1 December 1979
- journal article
- Published by Wiley in Journal of Veterinary Pharmacology and Therapeutics
- Vol. 2 (4) , 275-278
- https://doi.org/10.1111/j.1365-2885.1979.tb00401.x
Abstract
One hundred and eighteen isolates of Pseudomonas aeruginosa obtained from clinical material were tested for susceptibility to antimicrobial agents. Regardless of species of animal from which the isolate was obtained, 75% of the isolates were inhibited by ≤ 4 μg of gentamicin/ml, 100% by ≤ 4 μg of tobramycin/ml, 97% by ≤ 128 μg of carbenicillin/ml, and 2% by ≤ 64 μg of chloramphenicol/ml.Keywords
This publication has 4 references indexed in Scilit:
- Antibiotic Susceptibility Testing of Pseudomonas aeruginosa: Selection of a Control Strain and Criteria for Magnesium and Calcium Content in MediaThe Journal of Infectious Diseases, 1974
- In Vitro Antimicrobial Susceptibility Testing: Clinical Implications and LimitationsMedical Clinics of North America, 1974
- Comparative pharmacokinetics of tobramycin and gentamicinClinical Pharmacology & Therapeutics, 1973
- Intergeneric Transfer of a β-Lactamase Gene between Ps. aeruginosa and E. coliNature, 1970